Focused Alpha’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.41M Buy
9,436
+402
+4% +$56.4K 0.35% 52
2026
Q2
$1.14M Buy
9,034
+74
+0.8% +$9.8K 0.29% 70
2026
Q1
$1.25M Buy
8,960
+14
+0.2% +$1.96K 0.39% 49
2025
Q4
$1.1M Buy
+8,946
New +$1.09M 0.32% 62

Other funds holding GILD

Focused Alpha's GILD Position: Q3 2026 in Review

Focused Alpha increased its Gilead Sciences (GILD) stake by 4.4% in Q3 2026, buying an estimated $56.4K and bringing the position to 9,436 shares worth $1.41M. The position accounts for 0.35% of the portfolio, ranked #52.

Focused Alpha first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Focused Alpha held 9,436 shares of Gilead Sciences worth $1.41M as of Q3 2026.
  • Focused Alpha bought 402 Gilead Sciences shares in Q3 2026, an estimated $56.4K.
  • Gilead Sciences made up 0.35% of Focused Alpha's portfolio in Q3 2026, its #52 holding.
  • Focused Alpha first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.